HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyo Jung Kim Selected Research

R-CHOP protocol

1/2020Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
1/2019Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.
11/2017Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
4/2015Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyo Jung Kim Research Topics

Disease

38Neoplasms (Cancer)
08/2021 - 06/2003
14Multiple Myeloma
12/2021 - 08/2008
14Lymphoma (Lymphomas)
10/2019 - 06/2003
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2022 - 02/2011
7Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 10/2013
6Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2022 - 04/2010
6Inflammation (Inflammations)
03/2021 - 01/2004
5Cholangiocarcinoma
04/2022 - 01/2005
5Hepatocellular Carcinoma (Hepatoma)
05/2013 - 10/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010 - 10/2006
4Body Weight (Weight, Body)
01/2022 - 06/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 06/2006
4Neutropenia
10/2019 - 04/2010
4Disease Progression
10/2015 - 03/2009
4Melanoma (Melanoma, Malignant)
07/2015 - 03/2008
3Infections
10/2022 - 12/2004
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2022 - 05/2015
3Drug-Related Side Effects and Adverse Reactions
01/2022 - 04/2009
3Neoplasm Metastasis (Metastasis)
11/2021 - 06/2002
3Fibrosis (Cirrhosis)
06/2020 - 06/2007
3Gallstones (Gallstone)
01/2017 - 10/2003
3Vomiting
01/2016 - 09/2013
3Hypoxia (Hypoxemia)
01/2016 - 09/2007
3Nausea
01/2016 - 09/2013
3Obesity
01/2016 - 06/2011
3Pain (Aches)
01/2016 - 06/2002
3Stomach Neoplasms (Stomach Cancer)
10/2009 - 02/2009
2Febrile Neutropenia
10/2022 - 01/2019
2Thrombocytopenia (Thrombopenia)
07/2022 - 05/2015
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 04/2013
2Dizziness (Lightheadedness)
10/2021 - 08/2012
2Tuberculosis (Tuberculoses)
09/2021 - 07/2020
2Weight Loss (Weight Reduction)
04/2021 - 08/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2021 - 05/2007
2Cancer Pain
01/2021 - 04/2013
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 04/2016
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2020
2Breast Neoplasms (Breast Cancer)
11/2020 - 01/2020
2Fatigue
10/2019 - 03/2015
2Hyperpigmentation
10/2019 - 07/2015
2Benign Paroxysmal Positional Vertigo
04/2019 - 08/2012
2Asthma (Bronchial Asthma)
07/2018 - 11/2016
2Hypoalbuminemia
04/2018 - 06/2007
2Neoplasms, Cystic, Mucinous, and Serous
02/2017 - 01/2006

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
07/2020 - 06/2007
10Rituximab (Mabthera)FDA Link
10/2022 - 11/2010
10Dexamethasone (Maxidex)FDA LinkGeneric
04/2021 - 05/2010
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 11/2012
8AntioxidantsIBA
01/2022 - 06/2004
8Bortezomib (Velcade)FDA Link
01/2021 - 08/2008
7Prednisone (Sone)FDA LinkGeneric
01/2019 - 11/2012
6Vincristine (Oncovin)FDA LinkGeneric
10/2022 - 11/2012
6Cisplatin (Platino)FDA LinkGeneric
02/2016 - 10/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 11/2012
5Prednisolone (Predate)FDA LinkGeneric
10/2022 - 05/2010
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
5SteroidsIBA
01/2020 - 01/2011
5GemcitabineFDA Link
01/2017 - 10/2006
4Thalidomide (Thalomid)FDA Link
01/2021 - 05/2010
4Lenalidomide (CC 5013)FDA Link
01/2021 - 03/2015
4EnzymesIBA
06/2020 - 06/2004
4Pharmaceutical PreparationsIBA
01/2020 - 05/2007
4R-CHOP protocolIBA
01/2020 - 04/2015
4Monophenol Monooxygenase (Tyrosinase)IBA
07/2015 - 03/2008
4PhytoalexinsIBA
05/2013 - 02/2010
4ErbB Receptors (EGF Receptor)IBA
04/2009 - 10/2003
3Inosine Triphosphate (ITP)IBA
07/2022 - 05/2015
3Indicators and Reagents (Reagents)IBA
04/2022 - 01/2016
3DNA (Deoxyribonucleic Acid)IBA
09/2021 - 01/2011
3CollagenIBA
04/2021 - 06/2010
3Therapeutic UsesIBA
04/2020 - 11/2003
3Small Interfering RNA (siRNA)IBA
01/2020 - 04/2013
3GlucocorticoidsIBA
01/2020 - 12/2013
3Melphalan (Alkeran)FDA LinkGeneric
06/2017 - 05/2010
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016 - 05/2007
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 10/2009
3LigandsIBA
01/2016 - 07/2009
3Docetaxel (Taxotere)FDA Link
10/2010 - 02/2009
3Paclitaxel (Taxol)FDA LinkGeneric
04/2010 - 10/2008
3PPAR gammaIBA
12/2009 - 10/2006
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 03/2020
2CytokinesIBA
10/2021 - 10/2019
2MyostatinIBA
04/2021 - 01/2019
2LipidsIBA
01/2020 - 06/2011
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 01/2019
2Caspase 3 (Caspase-3)IBA
01/2020 - 04/2013
2BilirubinIBA
06/2018 - 06/2002
2AntigensIBA
06/2018 - 05/2016
2CarbohydratesIBA
06/2018 - 05/2016
2Daunorubicin (Cerubidine)FDA LinkGeneric
08/2017 - 10/2011
2glyceollinIBA
01/2017 - 02/2012

Therapy/Procedure

28Drug Therapy (Chemotherapy)
01/2021 - 06/2006
15Therapeutics
10/2021 - 07/2005
7Radiotherapy
09/2022 - 01/2016
7Combination Drug Therapy (Combination Chemotherapy)
09/2017 - 02/2009
5Stem Cell Transplantation
10/2017 - 10/2005
4Induction Chemotherapy
01/2022 - 06/2006
3Aftercare (After-Treatment)
01/2020 - 06/2015
2Oral Administration
06/2019 - 06/2011
2Transplantation
01/2018 - 06/2017